The indictment says four Southern California providers billed approximately $27.7 million and received roughly $26.9 million from the federal program, placing the extraordinary payment rate at the center of the government’s developing fraud case
WASHINGTON, DC — Medicare paid approximately $26,908,000 to four Southern California hospice companies controlled by Oren David Shachar after those providers submitted about $27,731,000 in claims that federal prosecutors now characterize as false and fraudulent.
The difference between the two figures is approximately $823,000, meaning the federal insurance program allegedly released about 97 percent of the money requested before investigators charged Shachar and two marketers in a 16-count indictment unsealed during June 2026.
Prosecutors say the paid claims covered hospice services that were medically unnecessary, ineligible for reimbursement, not delivered as represented, or obtained through kickbacks and bribes involving living beneficiaries, deceased people, marketers, clinicians, and sensitive identifying information.
Those accusations remain unproven, every defendant is presumed innocent unless convicted beyond a reasonable doubt, and the totals appearing in an indictment represent the government’s allegations rather than final findings concerning criminal loss, restitution, forfeiture, or personal responsibility.
The $26.9 Million Figure Changes the Story
The government’s federal indictment describing the alleged hospice billing operation distinguishes between money requested and money actually paid, a separation that transforms the case from an attempted billing narrative into an allegation involving substantial public funds already transferred.
Approximately $27,731,000 represents the claims that Shachar and others allegedly submitted or caused the four hospices to submit between February 2021 and March 2026, while approximately $26,908,000 represents payments Medicare allegedly made because of those submissions.
Dividing the alleged payments by the alleged billings produces a payment rate of roughly 97.03 percent, while the unpaid portion represents only about 2.97 percent of the total amount prosecutors say the providers sought from Medicare.
That narrow gap does not establish that Medicare approved every line exactly as submitted, because adjustments, denials, timing differences, payment rules, reconciliations, and claim-specific circumstances can affect the relationship between aggregate charges and aggregate reimbursement across several years.
Nevertheless, the proximity of the totals gives prosecutors a powerful financial narrative, because they can argue that the alleged conduct did not merely test billing controls but successfully converted disputed enrollment records and service representations into recurring federal payments.
Four Providers Generated the Aggregate Total
The indictment groups Gentle Touch Hospice Care in Valley Glen, Oxford Hospice Care in Montclair, Art of Hospice in Encino, and Holly Trinity Hospice in Glendale under the collective label describing the four Shachar hospices.
Federal prosecutors allege that Shachar owned, controlled, or operated those companies at different times, with the public filing describing his involvement in Art of Hospice from October 2019 and in the remaining providers from later dates.
Because each hospice maintained its own corporate identity, location, Medicare enrollment, provider number, records, employees, and claims history, investigators must reconstruct how the $26.9 million moved through separate billing streams rather than treating the companies as one undifferentiated account.
That reconstruction may reveal meaningful differences among the providers, including when billing accelerated, which beneficiaries moved between companies, how long enrollments continued, which marketers supplied referrals, and whether suspicious patterns followed particular personnel or ownership transitions.
The aggregate figure therefore provides scale, but provider-level evidence will determine whether every company participated in the same alleged methods, whether some claims were legitimate, and which transactions prosecutors can reliably connect to each charged defendant.
How Medicare Hospice Claims Become Payments
Medicare hospice coverage generally requires a physician’s certification that a beneficiary has a life expectancy of six months or less if the illness follows its expected course, alongside a signed election choosing palliative hospice care for the terminal condition.
The election carries consequences because Medicare generally stops covering treatment intended to cure the terminal illness once hospice is chosen, making informed consent and accurate communication essential protections rather than merely administrative paperwork supporting a provider’s reimbursement request.
Hospice care can include nursing, symptom-management drugs, medical equipment, social services, therapy, dietary counseling, and spiritual support, while continued coverage after initial benefit periods requires renewed clinical support and, at specified stages, an in-person evaluation.
To obtain payment, a provider submits claim information identifying the beneficiary, service type, service dates, attending clinician, and other billing details, usually through electronic systems operating upon representations that the underlying care and documentation comply with Medicare requirements.
When those data fields appear complete and consistent, a claim can satisfy ordinary processing rules even if investigators later allege that the terminal prognosis, consent, service history, referral arrangement, or record-creation chronology concealed facts that automated screening did not detect.
Payment Is Not a Government Warranty of Validity
The alleged 97 percent payment rate may invite the mistaken conclusion that Medicare thoroughly investigated and endorsed the medical legitimacy of nearly every claim, although large public programs necessarily process immense claim volumes through standardized electronic and administrative controls.
Payment ordinarily reflects that a submitted claim passed the controls applied at that stage, not that federal reviewers personally interviewed the beneficiary, independently examined every clinical judgment, authenticated every signature, reconstructed every visit, or investigated every financial relationship surrounding enrollment.
Retrospective investigations can combine information unavailable during routine processing, including bank records, device extractions, death data, witness interviews, employment access logs, messages, medical-record metadata, referral payments, and comparisons among providers that appear unrelated on individual claims.
That later evidence can cause claims that once looked complete to acquire a different meaning, particularly when authentic patient identifiers and plausible clinical details allegedly supported backdated records or care episodes that prosecutors say never occurred as represented.
For taxpayers, the payment ratio illustrates the challenge commonly described as paying first and pursuing recovery afterward, because even a successful prosecution may begin only after money has moved through businesses, accounts, compensation arrangements, purchases, and ordinary operating expenses.
Prosecutors Allege Three Main Billing Pathways
The indictment describes one pathway involving living beneficiaries whom Shachar, Abraham Shin, and others allegedly knew were not terminally ill, yet enrolled in the four hospices before claims were submitted for services that Medicare would not otherwise reimburse.
A second pathway allegedly used personal information belonging to recently deceased Medicare beneficiaries, enabling participants to create backdated enrollment and clinical records portraying services and terminal certifications as having occurred before each person’s actual death.
A third pathway involved allegedly unlawful referral and retention payments, including compensation to marketers, monthly cash for beneficiaries, household goods, alcohol, furniture, massages, televisions, medical equipment, and additional rewards for introducing new patients.
These theories overlap financially because an allegedly ineligible living beneficiary could generate repeated claims, an accepted deceased identity could support a shorter fabricated episode, and a paid referral could taint otherwise documented services if prosecutors establish the required statutory elements.
The $27.7 million billing total consequently does not describe one identical misrepresentation repeated thousands of times, but an aggregate of claims that prosecutors associate with different patients, providers, dates, records, inducements, and alleged reasons for reimbursement ineligibility.
That complexity gives the government a broad narrative while creating a demanding proof obligation, since prosecutors must show how particular claims fit particular theories and why the defendants knowingly caused materially false submissions rather than administrative errors or disputed clinical judgments.
Living Beneficiaries Allegedly Produced Recurring Revenue
Prosecutors allege that prospective patients were sometimes told the hospices offered quality-of-life assistance without being fully informed that hospice required terminal certification or that election could restrict Medicare coverage for curative treatment connected with the terminal condition.
Beneficiaries were allegedly offered as much as $400 each month to remain enrolled, creating a recurring incentive that prosecutors may compare against recurring Medicare payments received by the hospice during the same period for that person’s purported care.
Marketers were allegedly paid approximately $700 for every month that a referred living beneficiary remained billed, which would connect compensation directly with continued reimbursement and give recruiters a reason to resist discharge even when clinical circumstances changed.
The indictment also describes groceries, personal-care supplies, medical equipment, alcohol, televisions, massages, furniture, and reclining armchairs, items that may appear benevolent individually but allegedly functioned as inducements when tied to enrollment or continued participation.
If financial records align monthly beneficiary benefits, marketer compensation, and Medicare deposits around the same enrollment periods, prosecutors could present a circular economic system in which federal reimbursement financed the incentives that helped preserve future federal reimbursement.
Defense lawyers may respond that some assistance reflected ordinary patient support, that payments had lawful explanations, that beneficiaries genuinely qualified, or that survival and improvement do not retroactively establish a knowingly false terminal prognosis when enrollment originally occurred.
Deceased Beneficiaries Allegedly Created Shorter Claims
The government alleges that Jeannie Choi and Shin supplied Shachar with identifying information connected with deceased Medicare beneficiaries, including names, birth dates, Social Security numbers, Medicare identifiers, identification images, physician details, and next-of-kin information.
Shachar allegedly evaluated whether each deceased person had Medicare coverage and could plausibly have received hospice benefits while alive, after which relatives were contacted and recent hospital records were requested to support the purported pre-death episode.
Prosecutors say nurses, a physician, and others were directed to create false backdated electronic records stating that evaluations and terminal certifications happened before death, while family signatures were allegedly collected only after the beneficiary had died.
The alleged deceased-patient claims listed among the substantive counts are comparatively small, which may reflect compressed enrollment windows rather than low significance, because their evidentiary importance lies in proving billing for services that could not have occurred as represented.
Accurate death dates, authentic physician names, real hospital records, and valid Medicare identifiers could make a fabricated episode appear coherent to electronic screening, demonstrating why genuine data can become more dangerous than obviously invented information inside a reimbursement system.
This alleged channel also helps explain how the four hospices could present deaths among their patient populations, although prosecutors must prove which records were fabricated, who knew the truth, and whether each defendant intentionally advanced the resulting claims.
Eight Charged Claims Represent a Much Larger Allegation
Counts Two through Nine identify eight specific claims submitted from August 2023 through November 2025, with approximate billed amounts ranging from $220 to $6,270 and a combined listed value of approximately $32,360.
That combined amount equals only about 0.12 percent of the aggregate $27,731,000 alleged billing total, showing that the substantive execution counts serve as selected transactions rather than a claim-by-claim charging catalog covering every dollar in dispute.
The first five listed claims name Shachar, while the final three name Shachar, Choi, and Shin, reflecting the government’s allegation that the marketers entered the wider operation later and participated in a narrower group of transactions.
At trial, each selected claim can function as a detailed evidentiary case study involving one beneficiary, one provider, one date, one record sequence, and one billing submission, while the broader total may depend upon summary evidence and expert analysis.
Jurors cannot infer automatically that every uncharged claim was fraudulent merely because prosecutors prove one listed transaction, and defendants can challenge whether the government’s extrapolation, grouping, or aggregate methodology accurately distinguishes legitimate care from alleged misconduct.
Billed Amount, Paid Amount, and Legal Loss Differ
The $27,731,000 billed figure measures what prosecutors say the four providers requested, while the $26,908,000 paid figure measures what Medicare allegedly transferred, but neither number automatically becomes the final loss amount used for every legal purpose.
Criminal cases can involve different financial measures for charging, sentencing, restitution, forfeiture, money judgments, guideline calculations, and victim recovery, with each measure governed by its own legal standards and the evidence ultimately accepted by the court.
Defendants may argue that legitimate services possessed value, that some beneficiaries qualified, that certain claims were corrected or repaid, that amounts included lawful care, or that a defendant joining later cannot be assigned losses preceding any knowing participation.
Prosecutors may argue that claims procured through kickbacks, false eligibility representations, nonexistent services, or fabricated records caused Medicare to pay money it would not have released had the program known the concealed facts at submission.
The court may eventually receive competing spreadsheets, clinical analyses, claim histories, payment files, expert opinions, and witness testimony before determining any legally operative amount, making the indictment’s aggregate total an important starting allegation rather than the ending calculation.
The Payment Trail Can Reconstruct the Operation
Medicare payment files can show which hospice received each reimbursement, when money arrived, which beneficiary supported the claim, how long billing continued, and whether revenue patterns shifted after a marketer, clinician, or deceased-patient channel entered the operation.
Bank records can then trace whether provider deposits funded payroll, rent, legitimate care, marketer compensation, beneficiary benefits, transfers among related businesses, owner distributions, luxury purchases, tax payments, or withdrawals that prosecutors associate with alleged kickbacks.
Electronic records can supply a parallel chronology showing when assessments were entered, who accessed a chart, when certifications were signed, whether documentation was modified after death, and which user transmitted claims soon afterward.
Communications may connect those timelines by showing referral prices, beneficiary status, death information, promised goods, payment requests, or instructions about documentation, allowing investigators to compare what participants privately discussed with what the provider publicly represented to Medicare.
The strongest financial evidence would therefore combine a federal payment with independently authenticated proof that eligibility, consent, service delivery, or referral legality was knowingly misrepresented, rather than relying upon reimbursement alone as proof of criminal intent.
Conversely, legitimate medical documentation, credible service records, ordinary compensation explanations, missing messages, or proof that particular defendants lacked access and knowledge could weaken portions of the government’s proposed connection between a payment and an alleged fraud.
A Luxury Transaction Receives Its Own Count
Count Thirteen charges Shachar alone with an alleged monetary transaction involving criminally derived property, identifying a $15,000 wire sent from Holly Trinity Hospice’s bank account during September 2024 toward a lease-to-own down payment for a Rolls-Royce Phantom.
That transaction is legally and numerically separate from the aggregate payment allegation, yet prosecutors may use it to personalize the movement of funds by connecting a specific hospice account, a specific wire, and a conspicuous consumer asset.
The government must prove the statutory elements governing that charged transaction, including Shachar’s knowledge concerning criminally derived property, rather than assuming that an expensive vehicle becomes unlawful simply because money originated from a Medicare-participating provider.
Defense counsel can examine whether the transferred money was traceable to alleged fraud, commingled with legitimate revenue, characterized accurately, returned, financed differently, or handled by others, while prosecutors can rely upon tracing evidence and surrounding communications.
Recovery May Be Harder Than Calculating Payments
The indictment provides notice that prosecutors will seek forfeiture following any conviction and may pursue property traceable to specified offenses, an equivalent money judgment, or qualifying substitute assets when directly traceable proceeds cannot be located or recovered.
Restitution focuses upon compensating victims for legally recognized losses, while forfeiture targets property connected with crime, making the two remedies related but conceptually different even when both arise from the same stream of Medicare payments.
Money distributed through wages, rent, patient goods, referral compensation, taxes, debt payments, cash withdrawals, or third-party transfers may no longer remain in the original provider account, forcing investigators to reconstruct years of transactions and litigate ownership interests.
The $823,000 difference between alleged claims and payments cannot be treated as recovered money, because it merely represents the aggregate amount apparently not paid and says nothing about how much of the $26.9 million remains available to the government.
Contemporary Los Angeles reporting on the hospice fraud allegations noted that authorities had not publicly established how much money had been recovered, leaving an important distinction between identifying alleged loss and returning funds to Medicare.
Even substantial asset seizures may cover only part of an adjudicated loss after ownership claims, secured interests, valuation disputes, litigation expenses, depreciation, and competing restitution priorities are resolved through established federal legal procedures.
The Alleged Harm Extends Beyond Federal Dollars
Medicare’s nearly $27 million in alleged payments dominates the headline, but prosecutors also contend that beneficiaries were misled about hospice eligibility and the effect enrollment could have upon access to curative treatment under the federal program.
A patient incorrectly placed in hospice may encounter confusion when seeking treatment from a primary physician, specialist, hospital, pharmacy, or other provider, particularly if billing systems treat the hospice election as controlling coverage for the terminal condition.
Families may misunderstand why a loved one received hospice documentation, why particular services appear on Medicare records, or whether household goods were compassionate support rather than incentives connected with continued enrollment and reimbursement.
Deceased beneficiaries cannot examine statements or challenge impossible service dates, shifting detection toward relatives, clinicians, death-data matching, payment analytics, funeral-business controls, federal agencies, and investigators capable of connecting records across separate institutional boundaries.
Legitimate hospice providers can also suffer when major fraud allegations deepen public suspicion, because patients may become reluctant to accept appropriate comfort care while compliant organizations face greater audits, delayed payments, and reputational spillover from unrelated actors.
The public cost consequently includes investigative resources, administrative reviews, patient anxiety, provider disruption, and diminished trust, even before courts determine which claims were false and what portion of the alleged payment total represents recoverable criminal loss.
Why Authentic Identities Can Defeat Basic Controls
Electronic claim screening can readily identify malformed numbers, duplicate submissions, impossible provider combinations, or clearly ineligible records, yet authentic identifiers may satisfy those preliminary checks when the alleged deception concerns consent, chronology, medical necessity, or service delivery.
The Shachar indictment alleges that recently deceased people’s actual information was used to support backdated files, demonstrating how identity misuse can preserve surface consistency while secretly changing the events attached to an otherwise genuine beneficiary record.
Amicus International Consulting’s examination of identity crimes involving unauthorized personal information underscores the fundamental difference between lawfully updating one’s own government records and appropriating another person’s identifiers for transactions that person never authorized.
Healthcare integrity therefore requires more than matching a name with a valid Medicare number, because reliable payment decisions also depend upon proven authorization, accurate dates, legitimate clinical authorship, delivered services, eligible referrals, and transparent record provenance.
Funeral homes, hospices, hospitals, and insurers can strengthen those protections through limited access permissions, unusual-search alerts, restricted exports, personal-device controls, death-data comparisons, signature verification, and auditing that follows sensitive records across organizational boundaries.
High Payment Rates Expose a Prevention Challenge
A system that allegedly paid approximately 97 percent of disputed billings may prompt questions about whether prepayment controls relied too heavily upon complete data fields and too little upon behavioral patterns spanning providers, marketers, beneficiaries, and death records.
No screening system can resolve every clinical judgment before payment without delaying legitimate end-of-life care, creating a difficult balance between rapid support for vulnerable patients and deeper verification capable of identifying sophisticated or insider-assisted deception.
Useful warning patterns could include unusually long enrollments without clinical decline, repeated transfers among related hospices, identical documentation language, marketer-linked patient clusters, high live-discharge rates, claims shortly before recorded deaths, and notes entered after represented service dates.
Financial analytics can add another layer by identifying recurring payments associated with patient retention, rapid withdrawals after Medicare deposits, referral compensation tied to billed months, or provider revenue inconsistent with staffing, visits, medications, and other expected care costs.
Human reporting remains equally important because beneficiaries, relatives, nurses, billers, physicians, funeral employees, and competing providers may notice facts that claim algorithms cannot observe, including misleading conversations, nonexistent visits, backdating instructions, or unexplained requests for identifiers.
The payment ratio should therefore encourage targeted prevention and accountable review without becoming an argument for indiscriminately delaying every hospice claim, since excessive friction could burden families precisely when timely comfort care matters most.
Compliance Lessons for Hospice Operators
Hospice boards and owners should compare reimbursement against patient census, clinician capacity, visit records, medication costs, live discharges, length of stay, referral sources, complaints, and death outcomes rather than treating strong cash flow as proof of compliant operations.
Marketing contracts deserve particular scrutiny when compensation depends upon successful enrollment, continued billing, claim value, or the number of federally insured beneficiaries, because seemingly modest referral payments can create significant Anti-Kickback Statute exposure.
Beneficiary assistance should follow documented, lawful, consistently applied policies that prevent cash or valuable goods from becoming enrollment inducements, while staff must explain hospice elections plainly and preserve evidence that patients understood their choices.
Clinical records should identify who performed each assessment, when it occurred, what evidence supported terminal prognosis, and whether later changes were properly explained, with immutable audit logs capable of exposing backdating or unauthorized access.
Organizations should also rapidly reconcile dates of death, investigate claims created or modified afterward, separate sales activity from clinical decisions, and establish confidential reporting channels that protect employees who identify questionable enrollments or billing instructions.
Effective compliance is not merely a manual stored for accreditation, because the Shachar allegations describe operational incentives that would require active monitoring, independent authority, documented escalation, and meaningful consequences capable of challenging profitable conduct.
Payment Alone Cannot Prove Any Defendant’s Intent
The government may establish that Medicare transferred $26.9 million through objective program records, yet prosecutors still must prove that charged defendants knowingly joined, executed, or assisted the alleged fraud under the standards applicable to each count.
A paid claim can be medically wrong without being criminal, while a prognosis can prove inaccurate without having been dishonest, making knowledge and intent central when the dispute involves terminal eligibility rather than services demonstrably performed after death.
Shachar faces allegations spanning the entire operational period and provider network, whereas Shin and Choi are accused of joining during 2025, requiring careful limits upon which earlier payments and actions can fairly be attributed to each defendant.
The defense can challenge clinical conclusions, witness credibility, message context, payment descriptions, document authentication, government calculations, claim sampling, causation, and whether particular information was supplied with authorization or used beyond a defendant’s understanding.
Prosecutors can answer with converging evidence, such as referral messages, bank transfers, chart metadata, family testimony, impossible dates, repeated compensation, and provider deposits, but the burden remains proof beyond a reasonable doubt rather than numerical suspicion.
The fact that Medicare paid a claim may strengthen evidence of materiality and completed financial harm, yet it does not independently prove who created a falsehood, who knew it was false, or who intended the program to rely upon it.
Publicity Creates a Second Financial Crisis
Large reimbursement figures often dominate search results before evidence reaches trial, and allegations combining vulnerable seniors, deceased identities, alcohol, furniture, referral money, and a luxury automobile can inflict immediate commercial consequences upon defendants and associated businesses.
Amicus International Consulting’s framework for crisis public-relations planning during damaging allegations emphasizes accurate, coordinated communication, although any response during an active prosecution must remain aligned with defense counsel and must never influence witnesses, destroy records, or conceal assets.
Responsible statements can acknowledge the filed charges, preserve the presumption of innocence, correct demonstrable factual errors, distinguish the defendants’ roles, and avoid categorical claims that later medical records, financial evidence, or procedural developments may contradict.
Ethical reputation management cannot erase public court records or substitute for legal advocacy, but it can ensure that dismissals, pleas, verdicts, sentencing findings, recoveries, and verified compliance changes receive the same searchable accuracy as the original allegations.
News organizations carry a parallel duty to distinguish billed money from paid money, aggregate allegations from charged transactions, company revenue from personal gain, and an indictment from a conviction when describing a financially dramatic federal case.
Part of a Much Larger Enforcement Campaign
The Shachar indictment emerged during the 2026 National Health Care Fraud Takedown, which federal officials described as involving 455 defendants, 90 licensed medical professionals, 56 federal districts, and more than $6.5 billion in alleged false claims.
National figures provide context for the government’s enforcement priorities, yet they prove nothing about the three Shachar defendants because each count must rest upon admissible evidence connected with these hospices, beneficiaries, communications, and financial transactions.
The nationwide initiative also emphasized payment suspensions, billing revocations, asset seizures, international arrests, and data sharing, illustrating how criminal prosecution now operates beside administrative measures intended to stop reimbursement before every disputed claim reaches a courtroom.
For the Shachar hospices, however, the alleged 97 percent payment rate suggests that prevention came after most requested funds had already moved, making this case a particularly vivid example of the distance between claim processing and retrospective fraud detection.
What the $26.9 Million Will Mean Next
Pretrial litigation may address extensive claim data, protected medical records, clinical experts, electronic-record authentication, search procedures, payment tracing, witness statements, severance, forfeiture restraints, and whether evidence from one provider can be used against another defendant.
Prosecutors will likely seek to connect aggregate Medicare payments with specific enrollment practices, while defense lawyers may demand patient-level proof demonstrating why each challenged claim was knowingly false rather than medically debatable, technically deficient, or otherwise legitimate.
If convictions occur, later proceedings may determine loss, restitution, forfeiture, substitute assets, guideline effects, and responsibility among defendants, while acquittals or dismissals could narrow or reject the government’s proposed relationship between billing patterns and criminal conduct.
The final recoverable amount could differ materially from both headline figures because money may be unavailable, claims may be disputed individually, assets may belong to third parties, and legal standards may exclude amounts included within the indictment’s broader calculation.
Until that process concludes, the most accurate description remains that prosecutors allege approximately $27.7 million was billed and approximately $26.9 million was paid, not that a court has finally determined Medicare lost either amount precisely.
A Payment Ratio That Demands Explanation
The financial heart of the Shachar case is not simply that four hospices allegedly asked Medicare for a remarkable sum, but that the federal program allegedly paid nearly all of it while the purported operation continued across several years.
For prosecutors, that payment history may demonstrate completed harm, continuing opportunity, and proceeds capable of financing referrals, inducements, business expenses, and personal transactions, provided reliable evidence connects each disputed stream with knowing deception.
For the defense, the same history may support arguments that enrolled providers submitted facially valid claims, delivered valuable services, relied upon clinicians, and operated within a complicated program where payment disputes do not automatically establish fraudulent intent.
For Medicare and compliant hospice providers, the enduring question is how a system can release urgent end-of-life payments quickly while identifying authentic-looking records, paid referrals, concealed consent problems, and impossible service chronologies before millions of public dollars leave federal control.
Until the charges are resolved through dismissal, plea, trial, or later proceedings, the approximately $26.9 million remains both the case’s most consequential alleged result and a measure of how thoroughly prosecutors say the disputed claims penetrated Medicare’s payment system.
